• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾遗传性非息肉病性结直肠癌中hMSH2和hMLH1的低突变率

Low mutation rate of hMSH2 and hMLH1 in Taiwanese hereditary non-polyposis colorectal cancer.

作者信息

Wei S-C, Yu C-Y, Tsai-Wu J-J, Su Y-N, Sheu J-C, Wu C-H H, Wang C-Y, Wong J-M

机构信息

Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.

出版信息

Clin Genet. 2003 Sep;64(3):243-51. doi: 10.1034/j.1399-0004.2003.00123.x.

DOI:10.1034/j.1399-0004.2003.00123.x
PMID:12919140
Abstract

Hereditary non-polyposis colorectal cancer (HNPCC), the most common type of hereditary colorectal cancer, is thought to be a simple Mendelian disease involving DNA mismatch repair genes. The majority of mutations associated with HNPCC occur in the hMSH2 and hMLH1 genes. The reported incidence of mismatch repair gene mutations in HNPCC kindreds varies considerably (from 22 to 86%), and most mutations are unique. This study aimed to determine the genetic basis of Taiwanese HNPCC kindreds, focusing on the two major genes involved in this disease. A total of 15 Taiwanese HNPCC kindreds meeting the Amsterdam criteria, including 72 affected individuals among a total of 266 individuals, were analyzed using both RNA- and DNA-based methods. The mutation rate of hMSH2 and hMLH1 in these 15 kindreds was 0% and 20%, respectively, which is lower than that reported in other countries. Two novel mutations were discovered in hMLH1: one was an allelic loss of a 5.2-kb genomic fragment causing exon 16 deletion; and the other was a two-nucleotide deletion that resulted in a frameshift mutation of exon 3. We also identified one hMLH1 exon 4 mutation (a C to T transition in codon 117), which had been reported previously in western countries. This is the first genetic study of HNPCC from Taiwan.

摘要

遗传性非息肉病性结直肠癌(HNPCC)是最常见的遗传性结直肠癌类型,被认为是一种涉及DNA错配修复基因的简单孟德尔疾病。与HNPCC相关的大多数突变发生在hMSH2和hMLH1基因中。在HNPCC家系中报道的错配修复基因突变发生率差异很大(从22%到86%),而且大多数突变是独特的。本研究旨在确定台湾HNPCC家系的遗传基础,重点关注与该疾病相关的两个主要基因。使用基于RNA和DNA的方法对总共15个符合阿姆斯特丹标准的台湾HNPCC家系进行了分析,这些家系共有266人,其中72人患病。这15个家系中hMSH2和hMLH1的突变率分别为0%和20%,低于其他国家报道的突变率。在hMLH1中发现了两个新突变:一个是5.2 kb基因组片段的等位基因缺失,导致外显子16缺失;另一个是两个核苷酸的缺失,导致外显子3发生移码突变。我们还鉴定出一个hMLH1外显子4突变(密码子117处的C到T转换),这在西方国家之前已有报道。这是台湾首次对HNPCC进行的遗传学研究。

相似文献

1
Low mutation rate of hMSH2 and hMLH1 in Taiwanese hereditary non-polyposis colorectal cancer.台湾遗传性非息肉病性结直肠癌中hMSH2和hMLH1的低突变率
Clin Genet. 2003 Sep;64(3):243-51. doi: 10.1034/j.1399-0004.2003.00123.x.
2
Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.遗传性非息肉病性结直肠癌和早发性结直肠癌患者错配修复基因hMSH2和hMLH1启动子的突变分析:hMSH2基因启动子中三个新的种系突变的鉴定
Cancer Res. 2002 Jan 1;62(1):38-42.
3
Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.日本遗传性非息肉病性结直肠癌家系中hMSH2和/或hMLH1并发种系突变的鉴定。
Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1057-64.
4
Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.中国遗传性非息肉病性结直肠癌患者的临床特征及错配修复基因突变筛查
World J Gastroenterol. 2004 Sep 15;10(18):2647-51. doi: 10.3748/wjg.v10.i18.2647.
5
Germline hMLH1 promoter mutation in a Newfoundland HNPCC kindred.一个纽芬兰遗传性非息肉病性结直肠癌家系中的种系hMLH1启动子突变。
Clin Genet. 2003 Sep;64(3):220-7. doi: 10.1034/j.1399-0004.2003.t01-1-00110.x.
6
[Detection mutations in the DNA mismatch repair genes of hMLH1 and hMSH2 genes in Colombian families with suspicion of hereditary non-polyposis colorectal carcinoma (Lynch syndrome)].[对疑似遗传性非息肉病性结直肠癌(林奇综合征)的哥伦比亚家族中hMLH1和hMSH2基因的DNA错配修复基因进行突变检测]
Biomedica. 2005 Sep;25(3):315-24.
7
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.非裔美国结直肠癌患者中新型hMLH1和hMSH2种系突变
JAMA. 1999;281(24):2316-20. doi: 10.1001/jama.281.24.2316.
8
[Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].中国遗传性非息肉病性结直肠癌患者的临床特征及hMSH2/hMLH1种系突变筛查
Zhonghua Yi Xue Za Zhi. 2004 May 2;84(9):714-7.
9
Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.不符合阿姆斯特丹标准的遗传性非息肉病性结直肠癌家族中,错配修复基因突变的频率极低。
Am J Hum Genet. 1997 Aug;61(2):329-35. doi: 10.1086/514847.
10
[Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families].[中国遗传性非息肉病性结直肠癌家系中hMSH2和hMLH1基因的突变分析]
Zhonghua Bing Li Xue Za Zhi. 2003 Aug;32(4):323-8.

引用本文的文献

1
Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.结直肠癌中 hMLH1 和 hMSH2 基因病理性种系突变的流行率。
PLoS One. 2013;8(3):e51240. doi: 10.1371/journal.pone.0051240. Epub 2013 Mar 19.
2
Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?KRAS/BRAF 突变是否是结直肠癌强有力的预后和/或预测生物标志物?
Anticancer Agents Med Chem. 2012 Feb;12(2):163-71. doi: 10.2174/187152012799014968.
3
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer.
BRAF 突变是晚期和复发性结直肠癌强有力的预后因素。
Br J Cancer. 2011 Mar 1;104(5):856-62. doi: 10.1038/bjc.2011.19. Epub 2011 Feb 1.
4
Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polyposis colorectal cancer: a cost-effective screening strategy proposal.中国疑似遗传性非息肉病性结直肠癌的临床特征及错配修复基因分析:一项具有成本效益的筛查策略建议
Cancer Sci. 2008 Apr;99(4):770-80. doi: 10.1111/j.1349-7006.2008.00737.x. Epub 2008 Feb 27.
5
Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.癌症中的遗传和表观遗传生物标志物:改善诊断、风险评估和疾病分层
Mol Diagn Ther. 2006;10(1):1-15. doi: 10.1007/BF03256438.